Danazen Simvastatin Tablet 20 mg
Simvastatin 20mg
Tablet · Prescription medication
Daewon Biotech Co., Ltd.
MFDS item code 201907000 · Approved 2019.10.01
This product's status changed to Expired on 2024.10.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease
This medication is used to reduce the risk of cardiovascular disease. It decreases the risk of cardiovascular mortality and the occurrence of myocardial infarction and stroke in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, and stroke. It also lowers the risk of coronary and non-coronary vascular interventions. It is effective in treating hyperlipidemia, reducing total cholesterol, LDL cholesterol, and Apo-B protein levels while increasing HDL cholesterol, thus improving blood lipid status. It is used for primary and familial hypercholesterolemia as well as various dyslipidemias. Especially in pediatric patients with heterozygous familial hypercholesterolemia, it aids in lowering total cholesterol and LDL cholesterol levels as an adjunct to dietary therapy. This medication is used to improve cardiovascular health and prevent heart-related diseases.
Patients taking this medicine should follow a standard cholesterol-lowering diet before and during treatment. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose of this medicine is 20 mg once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see “Warnings”). 2) For recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), see the information below (see 6. Drug Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Take This Medicine under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Use in patients with renal impairment As this medicine is not substantially excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start treatment at 5 mg daily and monitor closely.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose for each patient as appropriate to achieve the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This medication may pose a risk of muscle problems, particularly at high doses, leading to serious muscle injury such as myopathy or rhabdomyolysis. It should not be used in patients with certain conditions or those taking specific medications; for example, patients with liver dysfunction or pregnant women, and those taking strong CYP3A4 inhibitors should not take this medication. Due to its potential impact on liver function, patients with liver disease or those who consume large amounts of alcohol should use this medication cautiously. Patients with reduced kidney function are also at higher risk for muscle damage, so caution is necessary. This medication should be administered cautiously in women, the elderly, and patients with hypothyroidism. Side effects such as muscle pain, weakness, abdominal pain, headache, and dyspepsia may occur, and if serious abnormal symptoms appear, consultation with a physician should be obtained immediately. Interactions with other drugs may increase the risk of muscle damage; therefore, if any other medications are being taken, patients must inform their doctor or pharmacist. Pregnant or breastfeeding women should not take this medication, and women who may become pregnant must use contraception while taking it. This medication is not to be used in children under 10 years old or pre-menstrual pediatric patients. Elderly patients may have increased blood concentration levels of this medication, necessitating dosage adjustment and careful monitoring. During treatment, liver function and muscle status should be regularly monitored for abnormalities. In case of overdose, immediate medical attention should be sought, and it should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering and kept at a temperature between 1°C and 30°C. Storing it this way will maintain the effectiveness and safety of the medication.
Oval film-coated tablet with yellowish-brown color
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Simvastatin 20mg
Tablet · Prescription medication
Daewon Biotech Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.